ES2768651T3 - Composición farmacéutica sólida - Google Patents

Composición farmacéutica sólida Download PDF

Info

Publication number
ES2768651T3
ES2768651T3 ES14787908T ES14787908T ES2768651T3 ES 2768651 T3 ES2768651 T3 ES 2768651T3 ES 14787908 T ES14787908 T ES 14787908T ES 14787908 T ES14787908 T ES 14787908T ES 2768651 T3 ES2768651 T3 ES 2768651T3
Authority
ES
Spain
Prior art keywords
tio
mpos
ico
tic
ica
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES14787908T
Other languages
English (en)
Spanish (es)
Inventor
Hiroshi Uchida
Masataka Hanada
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kyorin Pharmaceutical Co Ltd
Original Assignee
Kyorin Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyorin Pharmaceutical Co Ltd filed Critical Kyorin Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ES2768651T3 publication Critical patent/ES2768651T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F23/00—Mixing according to the phases to be mixed, e.g. dispersing or emulsifying
    • B01F23/20—Mixing gases with liquids
    • B01F23/23—Mixing gases with liquids by introducing gases into liquid media, e.g. for producing aerated liquids
    • B01F23/235—Mixing gases with liquids by introducing gases into liquid media, e.g. for producing aerated liquids for making foam

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ES14787908T 2013-04-25 2014-04-24 Composición farmacéutica sólida Active ES2768651T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2013092171 2013-04-25
PCT/JP2014/002308 WO2014174846A1 (ja) 2013-04-25 2014-04-24 固形医薬組成物

Publications (1)

Publication Number Publication Date
ES2768651T3 true ES2768651T3 (es) 2020-06-23

Family

ID=51791434

Family Applications (1)

Application Number Title Priority Date Filing Date
ES14787908T Active ES2768651T3 (es) 2013-04-25 2014-04-24 Composición farmacéutica sólida

Country Status (7)

Country Link
US (1) US9603804B2 (https=)
EP (1) EP2990038B1 (https=)
JP (2) JP5651812B1 (https=)
CN (1) CN105338982B (https=)
CA (1) CA2910112C (https=)
ES (1) ES2768651T3 (https=)
WO (1) WO2014174846A1 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014174847A1 (ja) 2013-04-25 2014-10-30 杏林製薬株式会社 固形医薬組成物
US10154993B2 (en) * 2014-10-23 2018-12-18 Kyorin Pharmaceutical Co., Ltd. Solid pharmaceutical composition
EP3210608A4 (en) * 2014-10-23 2018-06-20 Kyorin Pharmaceutical Co., Ltd. Solid pharmaceutical composition
EP3305294A4 (en) * 2015-06-02 2019-02-20 Kyorin Pharmaceutical Co., Ltd. AQUEOUS MEDICINE
JP6031217B1 (ja) * 2015-06-02 2016-11-24 杏林製薬株式会社 水性液剤
JP6675396B2 (ja) * 2015-06-02 2020-04-01 杏林製薬株式会社 水性液剤
WO2016195021A1 (ja) * 2015-06-02 2016-12-08 杏林製薬株式会社 水性液剤
JP6031216B1 (ja) * 2015-06-02 2016-11-24 杏林製薬株式会社 水性液剤
EP3773579A4 (en) 2018-03-26 2022-03-09 Clear Creek Bio, Inc. COMPOSITIONS AND METHODS FOR INHIBITING DIHYDROOROTATE DEHYDROGENASE
EP4121050A4 (en) * 2020-03-20 2024-04-17 Clear Creek Bio, Inc. STABLE POLYMORPHOUS COMPOSITIONS OF BREQUINA SODIUM, METHODS OF USE AND PRODUCTION THEREOF
US20210300873A1 (en) 2020-03-20 2021-09-30 Clear Creek Bio, Inc. Stable polymorphic compositions of brequinar sodium and methods of use and manufacture thereof

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8524001D0 (en) 1985-09-30 1985-11-06 Glaxo Group Ltd Pharmaceutical composition
KR940000232B1 (ko) 1986-01-17 1994-01-12 쥬우가이세이야꾸 가부시끼가이샤 니코란딜 제제의 안정화 방법
ZA87279B (en) 1986-01-17 1987-09-30 Chugai Pharmaceutical Co Ltd Method for production of stable nicorandil preparation
JP2512302B2 (ja) 1986-03-19 1996-07-03 中外製薬株式会社 ニコランジル安定化製剤の製造方法
ES2052245T3 (es) 1988-12-28 1994-07-01 Taisho Pharmaceutical Co Ltd Procedimiento de dispersion de las tensiones durante una operacion de formacion de tabletas.
JP2682353B2 (ja) 1991-11-20 1997-11-26 武田薬品工業株式会社 経口用医薬組成物およびその製造法
TW284688B (https=) 1991-11-20 1996-09-01 Takeda Pharm Industry Co Ltd
JP2006111639A (ja) 1993-10-21 2006-04-27 Takeda Chem Ind Ltd 医薬用錠剤
JPH08175996A (ja) 1994-12-22 1996-07-09 Taiyo Yakuhin Kogyo Kk ニコランジル安定化固形製剤の製法
JP3119801B2 (ja) 1995-09-28 2000-12-25 武田薬品工業株式会社 ビタミン含有組成物の安定化方法
JPH10245335A (ja) 1997-02-28 1998-09-14 Dainippon Pharmaceut Co Ltd 圧力に不安定な薬物の打錠方法及びそれに用いられる湿潤顆粒
ATE232728T1 (de) 1998-03-03 2003-03-15 Dae Woong Pharma Feuchtigkeitsstabile cefuroxim axetil enthaltende pharmazeutische zusammenstellungen
AT413647B (de) 1998-11-26 2006-04-15 Sandoz Ag Verwendung eines copolymerisats aus 1-vinyl-2-pyrrolidon und vinylacetat zur herstellung von cefuroximaxetil-hältigen tabletten
DE10048510A1 (de) 2000-09-29 2002-05-16 Fresenius Kabi De Gmbh Lagerstabile Infusionslösung des Ciprofloxacins mit verringertem Säuregehalt
KR20030087009A (ko) 2001-02-27 2003-11-12 랜박시 래보러터리스 리미티드 세프포독심 프록세틸의 경구용 약학 조성물
US7219132B2 (en) 2001-03-30 2007-05-15 Space Systems/Loral Dynamic resource allocation architecture for differentiated services over broadband communication networks
EP1486500B1 (en) 2002-03-18 2009-09-16 Kyorin Pharmaceutical Co., Ltd. 10-(3-cyclopropylaminomethyl-1-pyrrolidinyl)pyridobenzoxazinecarboxylic acid derivative effective against resistant bacteria
ES2297067T3 (es) 2003-03-19 2008-05-01 The Jordanian Pharmaceutical Manufacturing Co. Ltd. Composiciones farmaceuticas no higroscopicas que contienen acidos quinolinacarboxilicos de hidratados.
CN100410249C (zh) 2003-09-10 2008-08-13 杏林制药株式会社 7-(4-取代-3-环丙基氨基甲基-1-吡咯烷基)喹诺酮羧酸衍生物
MX2007000336A (es) 2004-07-02 2007-03-28 Daiichi Seiyaku Co Composicion medicinal que contiene quinolona.
AU2005283422C1 (en) 2004-09-17 2017-02-02 Eisai R & D Management Co., Ltd. Medicinal composition
WO2006059716A1 (ja) 2004-12-03 2006-06-08 Takeda Pharmaceutical Company Limited 固形製剤
AR052559A1 (es) 2005-01-21 2007-03-21 Astex Therapeutics Ltd Derivados de pirazol para inhibir cdk's y gsk's
ES2371145T3 (es) 2005-01-26 2011-12-27 Lek Pharmaceuticals D.D. Nueva composición farmacéutica que contiene candesartán cilexetilo como sustancia cristalina lipófila.
JP2006298811A (ja) 2005-04-20 2006-11-02 Taiyo Yakuhin Kogyo Kk ゲル化抑制製剤の設計
SA112330992B1 (ar) 2011-11-10 2015-09-13 كيورين فارماسوتيكال كو.، ليمتد صورة متبلرة من 7-{(s4، s3)-3-[(سيكلو بروبيل أمينو) ميثيل]-4-فلورو بيروليدين-1-يل}-6-فلورو-1-(2-فلورو إيثيل)- 8-ميثوكسي-4-أوكسو-1، 4-داي هيدرو كينولين-3- حمض كربوكسيلي
JP6050322B2 (ja) 2012-03-29 2016-12-21 杏林製薬株式会社 カプセル製剤
WO2013145750A1 (ja) * 2012-03-29 2013-10-03 杏林製薬株式会社 カプセル製剤
WO2014174847A1 (ja) 2013-04-25 2014-10-30 杏林製薬株式会社 固形医薬組成物

Also Published As

Publication number Publication date
US9603804B2 (en) 2017-03-28
EP2990038A1 (en) 2016-03-02
CN105338982B (zh) 2017-10-10
CA2910112A1 (en) 2014-10-30
JP2015078201A (ja) 2015-04-23
WO2014174846A1 (ja) 2014-10-30
EP2990038A4 (en) 2016-11-16
EP2990038B1 (en) 2019-11-20
US20160067185A1 (en) 2016-03-10
JP6391436B2 (ja) 2018-09-19
CN105338982A (zh) 2016-02-17
JPWO2014174846A1 (ja) 2017-02-23
JP5651812B1 (ja) 2015-01-14
CA2910112C (en) 2021-02-16

Similar Documents

Publication Publication Date Title
ES2768651T3 (es) Composición farmacéutica sólida
Scalera et al. A simple isolation method for basal-lateral plasma membranes from rat kidney cortex
US9815764B2 (en) Homochiral metal-organic framework with enantiopure pillar[5]arene active domains
US9329191B2 (en) Reaction-based fluorescent probe for selective detection of carbon monoxide using metal-mediated carbonylation
Yang et al. Diastereoselective synthesis of O symmetric heterometallic cubic cages
Chiocchio et al. Monoamines in the carotid body cells of the cat
CN110172028A (zh) 一种工业化生产妥洛特罗的方法
Saliba et al. Stimulating effect of both 4’‐O‐methylnorbelladine feeding and temporary immersion conditions on galanthamine and lycorine production by Leucojum aestivum L. bulblets
Meijers et al. Climate stability in central Anatolia during the Messinian Salinity Crisis
CN114014872B (zh) 青蒿琥酯衍生物及其制备方法和应用
Romolini et al. Shining Bright at 960 nm: A 28‐Silver‐Atom Nanorod Stabilized by DNA
Sundaresan et al. Alpha-and beta-adrenergic receptors in proximal tubules of rat kidney
CN109689667A (zh) 多孔手性材料及其用途
Sawada et al. Determination of enantiomeric excess for amino acid ester salts using FAB mass spectrometry
JPS6054345A (ja) エナンチオマ−を薄層クロマトグラフイ−分離する方法
Hannon et al. A cheap yet effective chiral stationary phase for chromatographic resolution of metallo-supramolecular helicates
Németh et al. Synthesis and pKa determination of new enantiopure dimethyl‐substituted acridino‐crown ethers containing a carboxyl group: Useful candidates for enantiomeric recognition studies
CN107525877B (zh) 一种采用液相色谱法分离测定依匹哌唑及其杂质的方法
US10828324B2 (en) Production of water-soluble hydrolyzed clinoptilolite fragments
Górecki et al. Circularly Polarized Luminescence From Spontaneous Symmetry Breaking in a Bimetallic Eu–Al Complex
AU720219B2 (en) New dosage form of hydroxocobalamin and its use in cyanide poisoning
Antoine Lanfranchi et al. Enantiomeric differentiation of atropine/hyoscyamine by 13C NMR spectroscopy and its application to Datura stramonium extract
Martin et al. Synthesis and anticancer activity of ruthenium half-sandwich complexes comprising combined metal centrochirality and planar chirality
Gregoliński et al. A New Synthetic Strategy Leading to Homochiral Macrocycles Derived from 2, 6‐Diformylpyridine and (1S, 2S)‐trans‐1, 2‐Diaminocyclopentane
Strauss THE PHYSIOLOGY OF POLLINATION INDUCED PHENOMENA IN THE ORCHIDACEAE.